December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The medical biomimetics market size is calculated at $38.59 bn in 2025 is to hit $74.87 bn by 2034. Medical biomimetics combines biology and technology to create innovative healthcare solutions, like biomaterials for tissue engineering, regenerative medicine, and drug delivery. Advances in R&D, biotech, and partnerships, such as Edwards Li...
November 01, 2025
Optical Genome Mapping (OGM) is advancing diagnostics for hematological malignancies and genetic diseases with its ability to detect complex genetic variations quickly and affordably. Highlighted at ASH 2024, its role in cancer research grows. AI integration further enhances genomics by analyzing vast data efficiently....
November 01, 2025
According to market projections, the cell culture sector is expected to grow from USD 20.61 billion in 2024 to USD 60.38 billion by 2034, reflecting a CAGR of 11.35%. The increasing incidences of chronic disorders, growing research and development, and technological advancements drive the market....
November 01, 2025
The cell culture vessels market size is calculated at $4.93 bn in 2025 is to hit $17.59 bn by 2034. The cell culture vessels market is growing rapidly due to their role in providing an ideal environment for cell growth. Made from materials like stainless steel, glass, or plastic, these vessels offer temperature control, air circulation, and microbi...
November 01, 2025
Projections indicate that, the global animal model market will increase from USD 2.54 billion in 2024 to USD 5.81 billion by 2034, experiencing a CAGR of 8.64% over the next 10 years. The growing research and development activities, rising incidences of chronic disorders, and increasing investments drive the market....
November 01, 2025
Market insights predict, the peptide synthesis industry is expected to grow from USD 686.59 million in 2024 to USD 2277.59 million by 2034, driven by a CAGR of 12.74%. The rising incidences of chronic disorders, growing research and development, and technological advancements drive the market....
November 01, 2025
The automated and closed cell therapy processing systems market size is calculated at $1.74 bn in 2025 is to hit $8.86 bn by 2034. The automated and closed cell therapy market sees key advancements: Cellular Origins partnered with Fresenius Kabi (Oct 2024) for robotic manufacturing; Multiply Labs collaborated with Stanford Medicine (Apr 2024) on au...
November 01, 2025
The cholera vaccines market size is calculated at $103.99 mn in 2025 is to hit $246 mn by 2034. In early 2025, Nakonde, Zambia, launched a cholera vaccination campaign targeting 191,153 people. In October 2024, India’s ICMR and NIRBD began a pilot project to vaccinate 50,000 individuals with Euvichol-Plus. In March 2024, IVI initiated a tech ...
November 01, 2025
According to market projections, the CRISPR technology sector is expected to grow from USD 5.72 billion in 2024 to USD 26.22 billion by 2034, reflecting a CAGR of 16.54%. In 2024, North America led the global CRISPR technology market, while Asia-Pacific is set for the fastest growth. Products dominated, but services are expected to grow the quickes...
November 01, 2025
According to market projections, the recombinant proteins sector is expected to grow from USD 3.05 billion in 2024 to USD 8.08 billion by 2034, reflecting a CAGR of 10.24%. In 2024, North America led the global recombinant proteins market with a 42% share. The cytokines & growth factors segment dominated by product, while antibodies are set for...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com